Author

Thomas Zwingers

Observed names: T Zwingers, Thomas ZWINGERS

Institution: Allergy Therapeutics (United Kingdom)

Observed institutions: University of Cologne, University of Würzburg, University Hospital Heidelberg, IPPMed (Germany), Klinikum Oldenburg, National Center for Tumor Diseases, Allergy Therapeutics (United Kingdom), Heinrich Heine University Düsseldorf, University of Duisburg-Essen, University of Göttingen, Charité – Universitätsmedizin Berlin, Ludwig-Maximilians-Universität München

OpenAlex ID: A5112758564

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

2002 · Hans-Peter Hartung, Richard Gonsette, et al. · The Lancet · 944

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

2014 · Brigitte Rack, Christian Schindlbeck, et al. · JNCI Journal of the National Cancer Institute · 615

PDF

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

2008 · Annina Herrmann, Eva Hoster, et al. · Journal of Clinical Oncology · 398

Systemic isotretinoin in the treatment of rosacea – doxycycline‐ and placebo‐controlled, randomized clinical study

2010 · Harald Gollnick, Ulrike Blume‐Peytavi, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 117

Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.

2010 · Brigitte Rack, Julia Jückstock, et al. · PubMed · 108

Gilbert's Syndrome and Irinotecan Toxicity: Combination with UDP-Glucuronosyltransferase 1A7 Variants Increases Risk

2008 · Tim O. Lankisch, Christoph Schulz, et al. · Cancer Epidemiology Biomarkers & Prevention · 93

PDF

Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases

1987 · Ulrich Dührsen, Wiprecht Augener, et al. · British Journal of Haematology · 87

Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group.

1999 · B Schlegelberger, T Zwingers, et al. · PubMed · 75

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

2010 · Ludwig Fischer von Weikersthal, Andreas Schalhorn, et al. · European Journal of Cancer · 55

UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer

2009 · Christoph Schulz, Volker Heinemann, et al. · World Journal of Gastroenterology · 52

PDF

Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses

2012 · Eggert STOCKFLETH, Thomas ZWINGERS, et al. · European Journal of Dermatology · 44

PDF

Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients

2011 · Brigitte Rack, Julia Jückstock, et al. · Archives of Gynecology and Obstetrics · 44

Is glutamine deficiency the link between inflammation, malnutrition, and fatigue in cancer patients?

2015 · Marcus Schlemmer, Ulrich Suchner, et al. · Clinical Nutrition · 41

Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study

2018 · Nikola S. Mutschler, Christoph Scholz, et al. · Clinical Breast Cancer · 32

Transdermal resorption of an ethanol- and 2-propanol-containing skin disinfectant

2007 · Martin Hartwig Kirschner, Reinhold Andreas Lang, et al. · Langenbeck s Archives of Surgery · 32

The bioavailability of calcium in the form of pyruvate, carbonate, citrate–malate in healthy postmenopausal women

2015 · Pawel Rzymski, Ivo Pischel, et al. · European Food Research and Technology · 22

PDF

Validation protocols for blood pressure-measuring devices

2015 · Beate Beime, Cornelia Deutsch, et al. · Blood Pressure Monitoring · 19

Interrater and Intrarater Variabilities in the Evaluation of Cutaneous Lymphoproliferative T-Cell Infiltrates

1994 · Günter Burg, Thomas Zwingers, et al. · Dermatologic Clinics · 19

Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML

2018 · Stephen O'Brien, Leanne Cork, et al. · Blood · 15

CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients

2016 · For the SUCCESS Study Group, Brigitte Rack, et al. · Tumor Biology · 14

Validation of the custo screen 400 ambulatory blood pressure-monitoring device according to the European Society of Hypertension International Protocol revision 2010

2014 · Peter Bramlage, Cornelia Deutsch, et al. · Vascular Health and Risk Management · 14

PDF

Systemisches Isotretinoin in der Behandlung der Rosazea – Doxycyclin‐ und plazebokontrollierte, randomisierte klinische Studie

2010 · Harald Gollnick, Ulrike Blume‐Peytavi, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 14

Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer

2012 · Alexandra Schönherr, Viktoria Aivazova-Fuchs, et al. · Breast Care · 13

PDF

Development and pilot phase of a European MS register

2010 · Peter Flachenecker, Laura Khil, et al. · Journal of Neurology · 13

The holo beta‐lactoglobulin lozenge reduces symptoms in cat allergy—Evaluation in an allergen exposure chamber and by titrated nasal allergen challenge

2023 · Karl‐Christian Bergmann, Jennifer Raab, et al. · Clinical and Translational Allergy · 11

PDF

Works count: 45

Citation count: 2,914

H-index: 18

I10-index: 26